Table 4.
Molecules | Origins | Experimental Approaches | Key Results | References |
---|---|---|---|---|
Proanthocyanidins | Chinese bayberry leaves | Platinum-resistant human ovarian cancer cell line OVCAR-3 Flow cytometry MTT assay Colony formation assay Western blot assay |
Induced inhibitory effects on the growth and CSC characteristics of OVCAR−3 SP cells Reduced the expression of β-catenin, cyclin D1, and c-Myc and inhibited the self-renewal capacity of cells Induced G1 cell cycle arrest in OVCAR−3 SP cells |
[58] |
Grape seed extract | Colorectal cancer cell lines, HCT116 and H716 Cell cycle and apoptosis analysis Cell viability and proliferation mRNA expression analysis Genome-wide RNA-sequencing analysisXenograft animal experiments |
Sensitized acquired (HCT116-FOr cells) and innately chemoresistant (H716 cells) cancer cells to 5-FU and oxaliplatin (OXP) PCs + (5-FU and OXP) inhibited the growth of chemoresistant cells and decreased the expression of several key adenosine triphosphate-binding cassette (ABC) transporters Sensitized chemoresistant cells to 5-FU and OXPPCs + (5-FU and OXP) reduced chemoresistant xenograft tumor growth in mice |
[59] | |
Tannic acid | Purchased | Malignant human cholangiocytes Calcein retention assays Western blot analysis RT-PCR |
Decreased malignant cholangiocyte growth Exhibited a synergistic effect with mitomycin C and 5-FU but not with Gem Decreased calcein efflux and expression of PGP, MRP1, and MRP2 membrane efflux pumps |
[60] |
Purchased | Liver cancer cell line HepG2 MTT assay Mitochondrial transmembrane potential qRT-PCR Western blot analysis |
Inhibited HepG2 cell growth TA + CP induced mitochondria-mediated apoptosis in HepG2 cells and enhanced growth inhibitory effect compared to treatment alone |
[61] | |
Procyanidins | Not reported | Laryngeal cancer cell line TU686 Flow cytometry Cell immunofluorescence staining Western blot analysis |
Inhibited TU686 cells in a concentration-dependent manner for 24 h Induced apoptosis of TU686 cells Increased expression of LC3−Ⅱ and Caspase-3 |
[62] |
Ellagic acid | Purchased | Colorectal carcinoma HT−29, Colo 320DM, SW480, and LoVo cells Trypan blue exclusion Annexin−V labeling Mitochondrial membrane potential (Δψm) Immunoblotting |
EA + 5-FU inhibited cell proliferation of HT-29, Colo 320DM and SW480 cells EA + 5-FU increased apoptotic cell death of HT−29 and Colo 320DM cells EA potentiated 5-FU chemosensitivity in at least three colorectal cancer cell lines |
[47] |
Purchased | Epithelial ovarian cancer cell line A2780MTT assay Immunoblot analysis Signal pathway analysis Cell cycle analysis |
Enhanced CP cytotoxicity in A2780CisR cells Prevented the development of CP resistance |
[48] | |
Purchased | Caco-2 and HTC-116 cells MTT assay In vitro drug release Male New Zealand white rabbits |
Induced higher cell viability than EA-NP treated HCT−116 cells Oral administration of EA-NPs caused a 3.6-fold increase in the area under the curve compared to that of EA (in vivo) |
[63] | |
Purchased | Rat C6 glioma cells Immunohistochemistry RT-PCR |
Reduced MGMT expression Affected the apoptotic proteins of p53 and caspase-3 at the protein level, but not at the gene level EA + bevacizumab (BEV) reduced cell viability EA + BEV reduced MDR1 expression only at 72 h |
[64] | |
Purchased | Rat C6 glioma cells Immunocytochemistry RT-PCR |
EA + TMZ reduced cell viability Down-regulated MGMT expression independent of the presence of TMZ EA + TMZ reduced MDR1 expression only over 48 h compared to TMZ alone Up-regulated caspase-3 at 48 h, but up-regulated p53 at 48 and 72 h EA + TMZ enhanced immunoreactivities of p53 and caspase-3 proteins, but not of the genes |
[65] | |
Purchased | Four human bladder cancer cell lines, TSGH−8301, TSGH-9202, T24, and J82 MTT assay Flow cytometry Cell migration and invasion assays Western blot analysis qRT−PCR Xenograft model |
Induced high cytotoxicity of Gem in GEM−resistant cells EA + Gem increased apoptosis and reduced cell motility in GCB-resistant cells Resensitized bladder cancer cells to Gem by reducing the epithelial–mesenchymal transition Reduced EMT by inhibiting the TGFβ−SMAD2/3 upward signaling pathway Inhibited the growth of bladder cancer tumors and increased the in vivo inhibitory effects of Gen on tumors |
[66] |